Recruiting

Cannabis

Sponsor:

Cannabis Research Associates

Code:

NCT03859089

Conditions

Pain Syndrome

Opioid Use

Cannabis Use

Eligibility Criteria

Sex: All

Age: 25+

Healthy Volunteers: Accepted

Interventions

Medical Cannabis

Study Details

Brief summary:

The purpose of this study is to define common strains of cannabis that adult chronic cancer and non-cancer pain syndrome patients are using as a replacement for opioids (narcotics). Identified strains, if any, will then be tested via randomized controlled trials to support an application for a Health Canada Drug Identification Number.

Conditions

Pain Syndrome

Opioid Use

Cannabis Use

Study ID

NCT03859089

Start date

Oct 10, 2017

Status verified date

Feb, 2019

Completion date

Oct 31, 2019

Anticipated

Primary completion date

Jun 30, 2019

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 25+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Adult patients aged > 25 years-CPSO Policy states that physicians cannot prescribe medical cannabis to persons under the age of 25 unless all other conventional therapies have failed. Furthermore, there is evidence to support that cannabis use in younger persons can have lasting effects since the brain is still developing (Wier K, 2015).
2. English-speaking, or with the assistance of a family member/friend that can interpret English for the patient.
3. Qualifying medical diagnosis for appropriate use of medical cannabis by a licensed physician.
4. Current medical cannabis use to treat chronic cancer and non-cancer pain syndromes.
5. Current or past use of prescription opioids to treat chronic cancer and non-cancer pain syndromes.

Exclusion Criteria:

1. Patients taking medical cannabis for reasons other than chronic cancer and non-cancer pain syndromes

Study Design

Enrollment

1200 participants

Anticipated

Interventions and Outcome Measures

Interventions

Medical Cannabis

N/A - Observational Cohort Study

Primary outcome measure

  • Cannabis as replacement for opioids [ Time Frame: Through study completion, an average of 1 year ]

Central Contacts and Locations

Central contacts

Andrea J Afinec, BScH

647 341-4230aafinec@gmail.com

Locations

Synergy Health Services Inc.

Recruiting

Hamilton, Ontario, Canada

Contacts

Ira Price, MD FRCPC

1-855-800-2226

More Information

Sponsor

Cannabis Research Associates

Last update posted

Mar 1, 2019

Last verified

Feb, 2019

Keywords

  • medical cannabis
  • opioids
  • pain
  • substitution
  • alternative

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Cannabis Research Associates on 2019-03-01.